Identification of clinically useful cancer prognostic factors: what are we missing? - PubMed (original) (raw)
Editorial
. 2005 Jul 20;97(14):1023-5.
doi: 10.1093/jnci/dji193.
- PMID: 16030294
- DOI: 10.1093/jnci/dji193
Editorial
Identification of clinically useful cancer prognostic factors: what are we missing?
Lisa M McShane et al. J Natl Cancer Inst. 2005.
No abstract available
Comment on
- Selective reporting biases in cancer prognostic factor studies.
Kyzas PA, Loizou KT, Ioannidis JP. Kyzas PA, et al. J Natl Cancer Inst. 2005 Jul 20;97(14):1043-55. doi: 10.1093/jnci/dji184. J Natl Cancer Inst. 2005. PMID: 16030302
Similar articles
- Selective reporting biases in cancer prognostic factor studies.
Kyzas PA, Loizou KT, Ioannidis JP. Kyzas PA, et al. J Natl Cancer Inst. 2005 Jul 20;97(14):1043-55. doi: 10.1093/jnci/dji184. J Natl Cancer Inst. 2005. PMID: 16030302 - Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice.
Chiesa F, Tradati N, Mauri S, Calabrese L, Grigolato R, Giugliano G, Zurrida S, Chiesa E, Squadrelli M, Viale G, Maiorano E. Chiesa F, et al. Anticancer Res. 1998 Nov-Dec;18(6B):4769-76. Anticancer Res. 1998. PMID: 9891555 - [Molecular markers of head and neck cancer].
Temam S, Janot F. Temam S, et al. Rev Prat. 2006 Oct 15;56(15):1658-61. Rev Prat. 2006. PMID: 17137250 Review. French. - Prognostic value of p53, Ki-67, microstaging and microvessel density in pT1G3 bladder tumors: creation of risk groups for progression.
Queipo-Zaragoza JA, Ruiz-Cerda JL, Vera-Donoso CD, Vera-Sempere F, Budia-Alba A, Jimenez-Cruz JF. Queipo-Zaragoza JA, et al. Scand J Urol Nephrol. 2007;41(4):283-9. doi: 10.1080/00365590601183055. Scand J Urol Nephrol. 2007. PMID: 17763218 - [Galectins in squamous cell carcinomas of the head and neck cancers].
Cada Z, Plzák J, Chovanec M, Dvoránková B, Lacina L, Szabó P, Smetana K Jr, Betka J. Cada Z, et al. Cas Lek Cesk. 2008;147(11):559-63. Cas Lek Cesk. 2008. PMID: 19097359 Review. Czech.
Cited by
- Statistical analysis of high-dimensional biomedical data: a gentle introduction to analytical goals, common approaches and challenges.
Rahnenführer J, De Bin R, Benner A, Ambrogi F, Lusa L, Boulesteix AL, Migliavacca E, Binder H, Michiels S, Sauerbrei W, McShane L; for topic group “High-dimensional data” (TG9) of the STRATOS initiative. Rahnenführer J, et al. BMC Med. 2023 May 15;21(1):182. doi: 10.1186/s12916-023-02858-y. BMC Med. 2023. PMID: 37189125 Free PMC article. Review. - Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype.
de Nonneville A, Finetti P, Boudin L, Denicolaï E, Birnbaum D, Mamessier E, Bertucci F. de Nonneville A, et al. Pharmaceutics. 2023 Mar 14;15(3):938. doi: 10.3390/pharmaceutics15030938. Pharmaceutics. 2023. PMID: 36986799 Free PMC article. - Structured reporting to improve transparency of analyses in prognostic marker studies.
Sauerbrei W, Haeussler T, Balmford J, Huebner M. Sauerbrei W, et al. BMC Med. 2022 May 12;20(1):184. doi: 10.1186/s12916-022-02304-5. BMC Med. 2022. PMID: 35546237 Free PMC article. Review. - Making External Validation Valid for Molecular Classifier Development.
Wu Y, Huang HC, Qin LX. Wu Y, et al. JCO Precis Oncol. 2021 Aug 5;5:PO.21.00103. doi: 10.1200/PO.21.00103. eCollection 2021 Aug. JCO Precis Oncol. 2021. PMID: 34377885 Free PMC article. - A Frailty Assessment Tool to Predict In-Hospital Mortality in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Gu JJ, Liu Q, Zheng LJ. Gu JJ, et al. Int J Chron Obstruct Pulmon Dis. 2021 Apr 20;16:1093-1100. doi: 10.2147/COPD.S300980. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33907395 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical